SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Deepmala, John Slattery, Nihit Kumar, Leanna Delhey, Michael Berk, Olivia Dean, Charles Spielholz, Richard Frye, Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review, Neuroscience & Biobehavioral Reviews, 2015, 55, 294

    CrossRef

  2. 2
    Nadezda Apostolova, Victor M. Victor, Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications, Antioxidants & Redox Signaling, 2015, 22, 8, 686

    CrossRef

  3. 3
    Georgina Oliver, Olivia Dean, David Camfield, Scott Blair-West, Chee Ng, Michael Berk, Jerome Sarris, N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review, Clinical Psychopharmacology and Neuroscience, 2015, 13, 1, 12

    CrossRef

  4. 4
    Ricardo Schneider, Carolina Ferreira Santos, Vanessa Clarimundo, Carla Dalmaz, Elaine Elisabetsky, Rosane Gomez, N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats, Alcohol, 2015, 49, 3, 259

    CrossRef

  5. 5
    I. E. Sommer, R. van Westrhenen, M. J. H. Begemann, L. D. de Witte, S. Leucht, R. S. Kahn, Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update, Schizophrenia Bulletin, 2014, 40, 1, 181

    CrossRef

  6. 6
    Gordon F. Rushworth, Ian L. Megson, Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits, Pharmacology & Therapeutics, 2014, 141, 2, 150

    CrossRef

  7. 7
    Shih-Ku Lin, Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature, British Journal of Clinical Pharmacology, 2014, 77, 2
  8. You have free access to this content8
    Jon E. Grant, Brian L. Odlaug, Liana R. N. Schreiber, Pharmacological treatments in pathological gambling, British Journal of Clinical Pharmacology, 2014, 77, 2
  9. 9
    Erin A. McClure, Cassandra D. Gipson, Robert J. Malcolm, Peter W. Kalivas, Kevin M. Gray, Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders, CNS Drugs, 2014, 28, 2, 95

    CrossRef

  10. 10
    Cassandra D. Gipson, Yonatan M. Kupchik, Peter W. Kalivas, Rapid, transient synaptic plasticity in addiction, Neuropharmacology, 2014, 76, 276

    CrossRef

  11. 11
    A. M. Weinstein, H. Miller, I. Bluvstein, E. Rapoport, S. Schreiber, R. Bar-Hamburger, M. Bloch, Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study, The American Journal of Drug and Alcohol Abuse, 2014, 40, 1, 16

    CrossRef

  12. 12
    Steven D. LaRowe, Peter W. Kalivas, Joyce S. Nicholas, Patrick K. Randall, Pascale N. Mardikian, Robert. J. Malcolm, A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence, The American Journal on Addictions, 2013, 22, 5
  13. 13
    Alessandra T. Peana, Valentina Giugliano, Michela Rosas, Marta Sabariego, Elio Acquas, Effects of l-Cysteine on Reinstatement of Ethanol-Seeking Behavior and on Reinstatement-Elicited Extracellular Signal–Regulated Kinase Phosphorylation in the Rat Nucleus Accumbens Shell, Alcoholism: Clinical and Experimental Research, 2013, 37,
  14. 14
    Yuval Samuni, Sara Goldstein, Olivia M. Dean, Michael Berk, The chemistry and biological activities of N-acetylcysteine, Biochimica et Biophysica Acta (BBA) - General Subjects, 2013, 1830, 8, 4117

    CrossRef

  15. 15
    Michael Berk, Gin S. Malhi, Laura J. Gray, Olivia M. Dean, The promise of N-acetylcysteine in neuropsychiatry, Trends in Pharmacological Sciences, 2013, 34, 3, 167

    CrossRef

  16. 16
    David Camfield, Advances in Natural Medicines, Nutraceuticals and Neurocognition, 2013,

    CrossRef

  17. 17
    M. Foster Olive, Richard M. Cleva, Peter W. Kalivas, Robert J. Malcolm, Glutamatergic medications for the treatment of drug and behavioral addictions, Pharmacology Biochemistry and Behavior, 2012, 100, 4, 801

    CrossRef

  18. 18
    Lianne Schmaal, Dick J Veltman, Aart Nederveen, Wim van den Brink, Anna E Goudriaan, N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study, Neuropsychopharmacology, 2012, 37, 9, 2143

    CrossRef

  19. 19
    Robert F. Leeman, Marc N. Potenza, Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity, Psychopharmacology, 2012, 219, 2, 469

    CrossRef

  20. 20
    Itai Danovitch, David A. Gorelick, State of the Art Treatments for Cannabis Dependence, Psychiatric Clinics of North America, 2012, 35, 2, 309

    CrossRef

  21. 21
    Jhodie R. Duncan, Andrew J. Lawrence, Addiction Neuroethics, 2012,

    CrossRef

  22. 22
    Daniele Mauro, Leonardo Procopio, “Blockade of Nitric Oxide Overproduction and Oxidative Stress by Nigella Sativa Oil Attenuates Morphine-Induced Tolerance” by Abdel-Zaher et al., Neurochemical Research, 2011, 36, 5, 924

    CrossRef

  23. 23
    Kathleen T. Brady, Kevin M. Gray, Bryan K. Tolliver, Cognitive enhancers in the treatment of substance use disorders: Clinical evidence, Pharmacology Biochemistry and Behavior, 2011, 99, 2, 285

    CrossRef

  24. 24
    Lianne Schmaal, Lotte Berk, Kai P. Hulstijn, Janna Cousijn, Reinout W. Wiers, Wim van den Brink, Efficacy of N-Acetylcysteine in the Treatment of Nicotine Dependence: A Double-Blind Placebo-Controlled Pilot Study, European Addiction Research, 2011, 17, 4, 211

    CrossRef

  25. 25
    Robert M. Post, Complex Combination Therapy for Long-Term Stability in Bipolar Disorder,
  26. 26
    Kushani Marshall, Linda Gowing, Robert Ali, Bernard Le Foll, Pharmacotherapies for cannabis dependence, The Cochrane Library,